University of Wisconsin Foundation
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), University of Wisconsin Foundation reported 6 stock positions worth $88.6 million. Its top holding was iShares Core S&P 500 ETF (IVV) at 32.9% of the portfolio, followed by Nu Holdings Ltd./Cayman Isl-A (NU, 19.3%) and Madrigal Pharmaceuticals (MDGL, 17.0%). Compared with Q4 2023, it opened 1 new position, added to 2 and reduced 2. The biggest buy was a new position in General Electric (GE) and the biggest sale Madrigal Pharmaceuticals (MDGL, shares −23%).
- Most Recent 13F
- Q2 2026
- Location
- MADISON, WI
- CIK
- 0001697228
- Portfolio Value
- $88.6M (Q1 2024)
- SEC Filing
- 0001697228-24-000002 ↗ filed May 14, 2024
Holdings Value
Holdings 6 stocks · $88.6M
| IVV iShares Core S&P 500 ETF | 32.89% | 55,443 | $29.1M | Add +55.0% |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 19.28% | 1,431,951 | $17.1M | Reduce -25.0% |
| MDGL Madrigal Pharmaceuticals Inc. | 16.99% | 56,376 | $15.1M | Reduce -23.3% |
| GE General Electric | 13.68% | 69,083 | $12.1M | New |
| AKRO Akero Therapeutics Inc. | 10.62% | 372,575 | $9.4M | No change |
| ETNB 89BIO Inc. | 6.54% | 498,137 | $5.8M | Add +293.7% |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $126.3M | SMH, CBRS, PDCC, PCVX, NU |
| Q1 2026 | 10 | $112.6M | PDCC, NU, PCVX, AAPL, SE |
| Q4 2025 | 8 | $118.9M | NU, PDCC, AAPL, NVDA, MSFT |
| Q3 2025 | 9 | $118.1M | PDCC, NU, AKRO, RNAM, NVDA |
| Q2 2025 | 5 | $89.4M | PDCC, NU, AKRO, MDGL, ETNB |
| Q1 2025 | 8 | $117.8M | SE, PDCC, MDGL, NU, AKRO |
| Q4 2024 | 7 | $137.6M | SE, PDCC, IVV, NU, MDGL |
| Q3 2024 | 7 | $153.3M | SE, IVV, PDCC, NU, AKRO |
| Q2 2024 | 6 | $88.8M | IVV, NU, MDGL, GE, AKRO |
| Q1 2024 | 6 | $88.6M | IVV, NU, MDGL, GE, AKRO |